30 related articles for article (PubMed ID: 38479181)
1. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
2. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
4. Vascular-targeted agents for the treatment of angiosarcoma.
Young RJ; Woll PJ; Staton CA; Reed MW; Brown NJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):259-70. PubMed ID: 24253175
[TBL] [Abstract][Full Text] [Related]
5. [Single-center study of different treatment for advanced or unresectable angiosarcoma patients].
Peng RQ; Xu BS; Liu YY; Yang QQ; Pan QZ; Zhang X
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):74-81. PubMed ID: 36709123
[No Abstract] [Full Text] [Related]
6. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.
Mendiola M; Saarela J; Escudero FJ; Heredia-Soto V; Potdar S; Rodriguez-Marrero S; Miguel M; Pozo-Kreilinger JJ; Berjon A; Ortiz-Cruz E; Feliu J; Redondo A
Biomed Pharmacother; 2024 Apr; 173():116397. PubMed ID: 38479181
[TBL] [Abstract][Full Text] [Related]
7. Angiosarcoma: state of the art and perspectives.
Penel N; Marréaud S; Robin YM; Hohenberger P
Crit Rev Oncol Hematol; 2011 Nov; 80(2):257-63. PubMed ID: 21055965
[TBL] [Abstract][Full Text] [Related]
8. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Italiano A; Toulmonde M; Bui-Nguyen B
Bull Cancer; 2010 Jun; 97(6):679-86. PubMed ID: 20483708
[TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of soft tissue sarcomas based on the histological subtype].
Pápai Z
Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
[TBL] [Abstract][Full Text] [Related]
11. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.
Gambini D; Visintin R; Locatelli E; Bareggi C; Galassi B; Runza L; Blundo C; Sosnovskikh I; Tomirotti M
Tumori; 2015 Apr; 101(2):e60-3. PubMed ID: 25744864
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Directions for Angiosarcoma Therapy.
Florou V; Wilky BA
Curr Treat Options Oncol; 2018 Mar; 19(3):14. PubMed ID: 29520447
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]